New disc may get heart patients walking faster after ablation

NCT ID NCT06627959

Ongoing Symptom relief Sponsor: Mid and South Essex NHS Foundation Trust Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a sticky disc called StatSeal helps people recover faster after a common heart procedure for atrial fibrillation. After the procedure, doctors must close the blood vessel in the leg to stop bleeding. Currently, they often use a stitch (figure-of-eight). This trial will randomly assign 160 patients to get either the disc or the stitch. The main goal is to see if the disc lets patients walk sooner, which could mean a quicker hospital discharge.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: StatSeal device (hemostatic disc) and figure-of-eight suture
What this could lead to: If StatSeal works better, patients may walk sooner after AF ablation, leading to faster discharge and improved comfort.
What could go wrong: This is a small, early-stage study (160 people). StatSeal may not speed recovery or could cause more side effects than the standard suture.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL FIBRILLATION (AF) VASCULAR ACCESS

Contacts and locations

Locations

East Sussex Healthcare NHS Trust

Eastbourne, BN21 2UD, United Kingdom
Norfolk and Norwich University Hospital

Norwich, NR4 7UY, United Kingdom
The Essex Cardiothoracic Centre

Basildon, Essex, SS16 5NL, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.